Tower Research Capital (TRC)’s Advent/Claymore Enhanced Gth & F LCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-833
Closed -$7K 4381
2017
Q2
$7K Buy
+833
New +$7.25K ﹤0.01% 1856
2016
Q2
Sell
-118
Closed -$1K 5341
2016
Q1
$1K Sell
118
-728
-86% -$5.72K ﹤0.01% 3930
2015
Q4
$7K Buy
+846
New +$7.17K ﹤0.01% 2674
2014
Q3
Sell
-100
Closed -$1K 5166
2014
Q2
$1K Hold
100
﹤0.01% 3847
2014
Q1
$1K Sell
100
-604
-86% -$6.24K ﹤0.01% 4280
2013
Q4
$7K Sell
704
-3,636
-84% -$36.1K ﹤0.01% 3341
2013
Q3
$42K Buy
4,340
+3,440
+382% +$34.1K ﹤0.01% 2082
2013
Q2
$9K Buy
+900
New +$8.97K ﹤0.01% 2502

Other funds holding LCM

Tower Research Capital (TRC)'s LCM Position: Q3 2017 in Review

Tower Research Capital (TRC) sold out of Advent/Claymore Enhanced Gth & F (LCM) in Q3 2017, closing a stake of 833 shares — an estimated $7K sold.

Tower Research Capital (TRC) first reported a position in LCM in Q2 2013 and held it in 8 quarters. The position peaked at $42K in Q3 2013. 25 funds tracked by Wall St. Rank hold LCM as of Q3 2017.

  • Tower Research Capital (TRC) reported no remaining Advent/Claymore Enhanced Gth & F position as of Q3 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 833 Advent/Claymore Enhanced Gth & F shares in Q3 2017, an estimated $7K.
  • Tower Research Capital (TRC) first reported a position in Advent/Claymore Enhanced Gth & F in Q2 2013 and held it in 8 quarters.
  • Tower Research Capital (TRC)'s Advent/Claymore Enhanced Gth & F position peaked at $42K in Q3 2013.
  • 25 funds tracked by Wall St. Rank held Advent/Claymore Enhanced Gth & F as of Q3 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.